Peer-reviewed journal articles (257)
  1. 107. Mijatovic, T., Mahieu, T., Bruyère, C., De Nève, N., Dewelle, J., Simon, G., Dehoux, M., van der Aar, E., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Van Quaquebeke, E., Darro, F., & Kiss, R. (2008). UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia (New York, N.Y.), 10(6), 573-586. doi:10.1593/neo.08290
  2. 108. Demetter, P., Nagy, N., Martin, B., Mathieu, A., Dumont, P., Decaestecker, C., & Salmon, I. (2008). The galectin family and digestive disease. Journal of pathology, 215(1), 1-12. doi:10.1002/path.2334
  3. 109. Le Mercier, M., Mathieu, V., Haibe-Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Kiss, R., & Lefranc, F. (2008). Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. Journal of neuropathology and experimental neurology, 67(5), 456-469. doi:10.1097/NEN.0b013e318170f892
  4. 110. Mijatovic, T., De Nève, N., Gailly, P., Mathieu, V., Haibe-Kains, B., Bontempi, G., Lapeira, J., Decaestecker, C., Facchini, V., & Kiss, R. (2008). Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Molecular cancer therapeutics, 7(5), 1285-1296. doi:10.1158/1535-7163.MCT-07-2241
  5. 111. Saussez, S., Decaestecker, C., Lorfevre, F., Chevalier, D., Mortuaire, G., Kaltner, H., André, S., Toubeau, G., Gabius, H.-J., & Leroy, X. (2008). Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology, 52(4), 483-493. doi:10.1111/j.1365-2559.2008.02973.x
  6. 112. Pozdzik, A., Salmon, I., Debelle, F., Decaestecker, C., Van den Branden, C., Verbeelen, D., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2008). Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney international, 73(5), 595-607. doi:10.1038/sj.ki.5002714
  7. 113. Lemy, A., Wissing, K. M., Rorive, S., Zlotta, A., Roumeguere, T., Muniz Martinez, M. C., Decaestecker, C., Salmon, I., Abramowicz, D., Vanherweghem, J.-L., & Nortier, J. (2008). Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. American journal of kidney diseases, 51(3), 471-477. doi:10.1053/j.ajkd.2007.11.015
  8. 114. Sadeghi-Meibodi, N., D'Haene, N., Decaestecker, C., Levivier, M., Metens, T., Maris, C., Wikler, D., Balériaux, D., Salmon, I., & Goldman, S. (2008). Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. American journal of neuroradiology, 29(3), 476-482. doi:10.3174/ajnr.A0851
  9. 115. D'Haene, N., Catteau, X., Maris, C., Martin, B., Salmon, I., & Decaestecker, C. (2008). Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas. British journal of haematology, 140(4), 402-410. doi:10.1111/j.1365-2141.2007.06929.x
  10. 116. Saussez, S., Lorfevre, F., Lequeux, T., Laurent, G., Chantrain, G., Vertongen, F., Toubeau, G., Decaestecker, C., & Kiss, R. (2008). The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy. Oral oncology, 44(1), 86-93. doi:10.1016/j.oraloncology.2006.12.014
  11. 117. Megalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P., Debeir, O., De Nève, N., Van Damme, M., Bontempi, G., Haibe-Kains, B., Decaestecker, C., Kondo, Y., Kiss, R., & Lefranc, F. (2007). 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 9(5), 358-369.
  12. 118. Saussez, S., Decaestecker, C., Lorfevre, F., Cucu, D.-R., Mortuaire, G., Chevalier, D., Wacreniez, A., Kaltner, H., André, S., Toubeau, G., Camby, I., Gabius, H.-J., & Kiss, R. (2007). High level of galectin-1 expression is a negative prognostic predictor of recurrence in laryngeal squamous cell carcinomas. International journal of oncology, 30(5), 1109-1117.
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Next >>